The Industry’s Most Comprehensive Kinase Profiling Service
KINOMEscan™ is an innovative, high-throughput method for screening small molecule compounds against large numbers of human kinases. By providing a fast, accurate, uniform and quantitative kinase profile that details how well each compound binds to both intended and unintended targets, KINOMEscan™ transforms the promiscuity of kinase inhibitors into a discovery advantage.
The KINOMEscan™ Advantage
- Largest available kinase profiling panel
- High-quality accurate, precise, reproducible data
- Rapid turnaround supports lead optimization
- Premium customer support and competitive pricing
- Flexible screening services and personalized solutions
- Detect non-type I inhibitors
- TREEspot Data Visualization Tool
 |
New & Enhanced Kinase Panel: 442 Kinase Assays
KINOMEscan announces the expansion of its kinase assay panel with the release of almost fifty new and enhanced kinase assays. As a leading profiling service provider with the industry’s most comprehensive panel of kinase assays, KINOMEscan continues to redefine the standard in high-throughput selectivity and off-target profiling. View our new assays and see what you are missing! |
New Kinase Panel Highlights:
- MTOR, LRRK2, LRRK2(G2019S), CDK4-cyclinD1, CDK4-cyclinD3
- Three pathogen kinases including M. tuberculosis and P. falciparum
- New lipid, tyrosine, and mutant kinase assays
- scanMODE activated/non-activated assay pairs to elucidate compound binding mode.
Kinase Screening Services Available
| scanMAX |
scanMAX (442): Best choice for drug discovery and compound optimization
Definitive set of 442 kinases – the largest panel commercially available – covering all major kinase groups. |
 |
scanEDGE (96): An economical approach to surveying the human kinome
Contains a set of 96 kinases distributed throughout the kinome. |
 |
scanLIPID (20): The largest commercial panel of human lipid kinases. Includes PIK3, PIK4, and PIP lipid kinase families. |
| scanTK |
scanTK (127): The world’s most complete collection of tyrosine kinases. |
 |
scanELECT (1-442): Ultimate flexibility for custom applications
An a-la-carte approach to exploring kinases of interest. Choose only the kinases you want. |
| scanMode |
NEW! scanMODE (12): Employs activated/non-activated assay pairs to elucidate compound binding mode. An ideal tool for understanding how kinase phosphorylation state affects inhibitor affinity. |
